Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jun;7(1):1-17.
doi: 10.1007/s40123-017-0115-5. Epub 2017 Nov 30.

A Review of the Landscape of Targeted Immunomodulatory Therapies for Non-Infectious Uveitis

Srilakshmi M Sharma  1   2 , Dun Jack Fu  3 , Kanmin Xue  3   4
Affiliations
Review

A Review of the Landscape of Targeted Immunomodulatory Therapies for Non-Infectious Uveitis

Srilakshmi M Sharma et al. Ophthalmol Ther. 2018 Jun.

Abstract

Systemic immunomodulatory therapies are the principal means of managing non-infectious uveitis. This review aims to explore the current landscape of systemic uveitis treatments, including biologic therapies and the advent of biosimilar therapies.

Keywords: Biologics; Biosimilars; Interferon; Interleukins; Non-infectious uveitis; TNFα inhibitors.

PubMed Disclaimer

References

    1. Al-Rayes H, Al-Swailem R, Al-Balawi M, Al-Dohayan N, Al-Zaidi S, Tariq M. Safety and efficacy of infliximab therapy in active Behcet’s uveitis: an open-label trial. Rheumatol Int. 2008;29(1):53–57. doi: 10.1007/s00296-008-0606-8. - DOI - PubMed
    1. Angeles-Han S, Flynn T, Lehman T. Abatacept for refractory juvenile idiopathic arthritis-associated uveitis- a case report. J Rheumatol. 2008;35(9):1897–1898. - PubMed
    1. Artornsombudh P, Gevorgyan O, Payal A, Siddique SS, Foster CS. Infliximab treatment of patients with birdshot retinochoroidopathy. Ophthalmology. 2013;120(3):588–592. doi: 10.1016/j.ophtha.2012.05.048. - DOI - PubMed
    1. Baarsma GS. The epidemiology and genetics of endogenous uveitis: a review. Curr Eye Res. 1992;11(Suppl):1–9. doi: 10.3109/02713689208999505. - DOI - PubMed
    1. Baert F, Noman M, Vermeire S, Van Assche G, D’Haens G, Carbonez A, Rutgeerts P. Influence of immunogenicity on the long-term efficacy of infliximab in Crohn’s disease. N Engl J Med. 2003;348(7):601–608. doi: 10.1056/NEJMoa020888. - DOI - PubMed

LinkOut - more resources